Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
21 May 2020
Markets for You
Global Indices
Global Indices 20-May Prev_Day Abs. Change
% Change
Russell 3000 1,455 1,431 25 1.72
Nasdaq 9,376 9,185 191 2.08
FTSE 6,067 6,002 65 1.08
Nikkei 20,595 20,433 162 0.79
Hang Seng 24,400 24,388 12 0.05
Indian Indices 20-May Prev_Day Abs. Change
% Change
S&P BSE Sensex 30,819 30,196 622 2.06
Nifty 50 9,067 8,879 187 2.11
Nifty 100 9,249 9,060 189 2.09
Nifty 500 7,427 7,285 142 1.95
Nifty Bank 17,840 17,486 354 2.02
S&P BSE Power 1,443 1,431 13 0.89
S&P BSE Small Cap
10,472 10,355 117 1.13
S&P BSE HC 15,354 14,883 471 3.16
Date P/E Div. Yield P/E Div. Yield
20-May 19.25 1.22 21.16 1.68
Month Ago 19.21 1.36 20.75 1.64
Year Ago 29.05 1.18 29.48 1.11
Nifty 50 Top 3 Gainers
Company 20-May Prev_Day
% Change
Shree Cements Limited 19412 18341 5.84
M&M 405 383 5.78
Dr.Reddy 3910 3700 5.69
Nifty 50 Top 3 Losers Domestic News
Company 20-May Prev_Day
% Change
Bharti Infratel 201 219 -8.18
IndusInd Bank 357 368 -2.85
Hero Moto 2024 2074 -2.41
Advance Decline Ratio
Advances 1262 1056
Declines 1060 707
Unchanged 164 139
Institutional Flows (Equity)
Description (Cr)
FII Flows* -43918
MF Flows** 32626
May 2020; **19
May 2020
Economic Indicator
YoY(%) Current Year Ago
Data as on 19 May 2020
Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
21 May 2020
Since May-17, MOSPI has revised base year of IIP & WPI from 2004-05 to 2011-12, and for CPI from
2010 to 2012
Indian Equity Market
Indices Performance
P/E Dividend Yield
Quarter Ago
Indian equity markets surged led by strong buying in the financial stocks.
Investors found reassurance from the finance minister statement that
government is with the industry and shall do as much as possible to repair
the damage when companies were going through the most stressful time.
Key benchmark indices S&P BSE Sensex and Nifty 50 gained 2.06% and
2.11% to close at 30,818.61 and 9,066.55 respectively. S&P BSE MidCap and
S&P BSE SmallCap gained 1.49% and 1.13% respectively.
The overall market breadth on BSE was strong with 1,262 scrips advancing
and 1,060 scrips declining. A total of 164 scrips remained unchanged.
All the sectors gained. S&P BSE Healthcare was the major gainer, up 3.16%,
followed by S&P BSE Capital Goods and S&P BSE Consumer Durables, up
3.12% and 2.68%, respectively. S&P BSE Oil & Gas and S&P BSE Realty
gained 2.52% and 2.39% respectively.
According to Ratings agency ICRA, India’s economic growth has been
sharply revised to 5% contraction for FY20-21 from 1% to 2% growth
earlier. Rating agency also estimated sharper de-growth in the Jun and Sep
quarter of 2020 at -25% and -2.1% respectively, down from a range of 16%-
20% contraction in and 2.1% growth, respectively before. The report cited
the extended lockdown and labour mismatches causing further delays in
supply chain resumption as the reason for the downgrade.
Considering the impact of the lockdown on India’s economic activity, the
government said that it was cautiously optimistic about the revival of
growth later in the year. Actual GDP growth in FY20-21 would be
depending upon the intensity, spread and duration of the Covid-19
pandemic. However, in its macroeconomic report, the finance ministry did
not disclose its projections for FY20-21.
The finance ministry has sanctioned Rs. 46,038.70 crore for May 2020
instalment of devolution of states' share in central taxes and duties. The
amount has been calculated based on tax receipts projected in Budget
2020-21 & not as per actuals.
The Union Cabinet eased the norms of the Partial Credit Guarantee Scheme
and extended its time period in order to widen the coverage to include a
larger number of NBFCs, HFCs and micro finance institutions.
Majority of the Asian markets rose on hopes that a continued drop in new
daily Covid-19 cases will help the global economy recover from the
coronavirus crisis. However, gains were largely restricted following reports
questioning the validity of the U.S. bio pharma’s early trial results for a
possible coronavirus vaccine. Today (as on May 21), Asian markets rose
following rise on Wall Street overnight. Both Nikkei and Hang Seng market
traded up 0.37% and 0.53%, respectively (as at 8.a.m. IST).
European markets closed on a strong note despite weak start. Market
participants bought stocks on the back of optimism about economic
recovery thanks to reopening of businesses. Initially, market was weak on a
report that doubted a U.S. pharma company’s claim about the positive
results of a potential coronavirus vaccine.
U.S. markets rose sharply on continued optimism about an economic
recovery as states begin to reopen following the coronavirus-induced
lockdowns. Initial signals suggest the states that have reopened have not
seen a spike in coronavirus cases. This raised hopes that the economy may
rebound more rapidly than many economists predict.
Markets for You